Key | % Net Assets |
---|---|
Treausry 0% 9 July 2012 | 9.6% |
AstraZeneca | 4.4% |
Royal & Sun Alliance | 4.3% |
Reed Elsevier | 4.1% |
Other | 77.6% |
Name | % Net Assets |
---|---|
Treausry 0% 9 July 2012 | 9.6% |
AstraZeneca | 4.4% |
Royal & Sun Alliance | 4.3% |
Reed Elsevier | 4.1% |
Treasury 0% 2012 | 3.7% |
BP | 3.3% |
Amlin 6.5% 2026 | 3.2% |
ETFS Physical Gold | 3.1% |
Treasury 0% 6 June 2012 | 2.7% |
Treasury Bill 3 Sep 2012 | 0.0% |
No asset data available.
Date | n/a |
---|---|
Bid | 0.00 |
Offer | 0.00 |
Currency | n/a |
Change | 0.00 |
% | n/a |
YTD change | 0.00 |
YTD % | n/a |
Fund Inception | n/a |
---|---|
Fund Manager | n/a |
TER | - |
Minimum Investment | |
---|---|
Initial | n/a |
Additional | n/a |
Savings | n/a |
Charges | |
---|---|
Initial | n/a |
Annual Mang't | n/a |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research